Insmed Incorporated
LSE: 0JAV.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- William H. Lewis
- Employees
- 1,271
- Headquarters
- Bridgewater, United States
- IPO year
- 2018
- Market cap
- $21.8B
- Website
- https://www.insmed.com
Loading 0JAV…
Loading profile data…Frequently asked questions about 0JAV
What does Insmed Incorporated (0JAV.L) do?
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
Where does 0JAV.L trade?
Insmed Incorporated (0JAV.L) trades on the London Stock Exchange.
What sector is 0JAV.L in?
Insmed Incorporated (0JAV.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Insmed Incorporated?
William H. Lewis is the chief executive officer of Insmed Incorporated (0JAV.L).
Where is Insmed Incorporated headquartered?
Insmed Incorporated is headquartered in United States.
Does 0JAV.L pay a dividend?
Insmed Incorporated (0JAV.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0JAV.L go public?
Insmed Incorporated (0JAV.L) completed its initial public offering in 2018.